Results 11 to 20 of about 72,473 (300)

False memories in Lewy-body disease [PDF]

Scandinavian Journal of Psychology, 2015
Recently, de Boysson et al. (2011) [de Boysson, C., et al. (2011). False recognition in Lewy-body disease and frontotemporal dementia. Brain and Cognition, 75, 111-118.] found that patients with Lewy-body disease (LBD) showed significantly lower rates of
Abe, Anderson, Balota, Balota, Basile, Boysson, Brainerd, Budson, Budson, Budson, Budson, Cummings, Dennis, Folstein, Gallo, Gallo, Golden, Gómez-Ariza, Hudon, Kaplan, Koen, Mahoney, McKeith, McKeith, Norman, Old, Peña-Casanova, Plancher, Reisberg, Reitan, Rey, Reyna, Roediger, Roediger, Schoemaker, Sheikh, Snodgrass, Tabachnick, Toglia, Tussing, Walker, Watson, Wechsler, Yonelinas, Yonelinas   +44 more
core   +5 more sources

Matters Arising ‘Lewy body disease or diseases with Lewy bodies?’

npj Parkinson's Disease, 2022
Kurt A. Jellinger
doaj   +3 more sources

Reply: Matters Arising ‘Lewy body disease or diseases with Lewy bodies?’

npj Parkinson's Disease, 2022
Kateřina Menšíková, Radoslav Matěj, Carlo Colosimo, Raymond Rosales, Lucie Tučková, Jiří Ehrmann, Dominik Hraboš, Kristýna Kolaříková, Radek Vodička, Radek Vrtěl, Martin Procházka, Martin Nevrlý, Michaela Kaiserová, Sandra Kurčová, Pavel Otruba, Petr Kaňovský   +15 more
doaj   +3 more sources

Alterations in peptide levels in Parkinson's disease and incidental Lewy body disease [PDF]

, 2007
The levels of the neuropeptides Met- and Leu-enkephalin (MET-ENK, LEU-ENK), substance P and neurotensin were measured by a combined high performance liquid chromatography/radioimmunoassay (HPLC/RIA) method in postmortem samples of basal ganglia from ...
Beyer, Cordian, Dang, Jon, Habib, Pardes, Hoffmann, Stefanie, Lammerding, Leoni, Slowik, Alexander, Zendedel, Adib   +6 more
core   +1 more source

RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia—an international Delphi consensus

Alzheimer’s Research & Therapy, 2022
Drug repositioning and repurposing has proved useful in identifying new treatments for many diseases, which can then rapidly be brought into clinical practice.
John T. O’Brien, Leonidas Chouliaras, Janet Sultana, John-Paul Taylor, Clive Ballard, on behalf of the RENEWAL Study Group   +5 more
doaj   +1 more source

The Alzheimer variant of Lewy body disease: A pathologically confirmed case-control study [PDF]

, 2005
The objective of the study was to identify clinical features that distinguish patients with dementia with Lewy bodies (DLB), who were classified as Alzheimer's disease ( AD) patients, from patients with AD.
Busch, R., Förstl, Hans, Kretzschmar, H., Kurz, A., Mösch, D., Müller, U., Neumann, M., Perneczky, R.   +7 more
core   +1 more source

Mixed Brain Pathologies in Dementia: The BrainNet Europe Consortium Experience [PDF]

, 2008
Background: Dementia results from heterogeneous diseases of the brain. Mixed disease forms are increasingly recognized. Methods: We performed a survey within brain banks of BrainNet Europe to estimate the proportion of mixed disease forms underlying ...
Al-Sarraj, Safa, Alafuzoff, Irina, Arzberger, Thomas, Bogdanovic, Nenad, Budka, Herbert, Capellari, Sabina, Ferrer, Isidro, Gelpi, Ellen, Kovacs, Gabor G., Kovari, Viktor, Kretzschmar, Hans, Nagy, Zoltan, Parchi, Piero, Seilhean, Danielle, Soininen, Hilkka, Troakes, Claire   +15 more
core   +1 more source

Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. [PDF]

, 2019
The gold standard for a definitive diagnosis of Parkinson disease (PD) is the pathologic finding of aggregated α-synuclein into Lewy bodies and for Alzheimer disease (AD) aggregated amyloid into plaques and hyperphosphorylated tau into tangles.
Brundin, P, Cambi, F, Espay, AJ, Fasano, A, Fernandez, HH, Gan-Or, Z, Greenamyre, JT, Josephs, KA, Kauffman, MA, Lang, AE, Leverenz, JB, Litvan, I, Marsili, L, Mata, IF, Merola, A, Morgante, F, Perry, G, Sardi, SP, Savica, R, Schwarzschild, MA, Sherer, T, Simon, DK, Standaert, DG, Tanner, CM, Vizcarra, JA, Yamasaki, TR, Zabetian, CP   +26 more
core   +3 more sources

Cortical Lewy body disease [PDF]

Journal of Neurology, Neurosurgery & Psychiatry, 2004
Cortical Lewy body disease reflects the presence of cortical Lewy bodies but without a clear clinical correlation Cortical Lewy body disease is a pathological observation rather than a distinct clinicopathological entity. Cortical Lewy bodies (CLB) are typically found in Parkinson’s disease and dementia with Lewy bodies (DLB), although they may also ...
openaire   +2 more sources

Neuroinflammation in Lewy body dementia. [PDF]

, 2015
Neuroinflammation is increasingly recognized as a key factor in the pathogenesis of neurodegenerative conditions. However, it remains unclear whether it has a protective or damaging role.
O'Brien, John T, Rowe, James B, Surendranathan, Ajenthan   +2 more
core   +2 more sources